Palisade Bio Stock Technical Analysis
| PALI Stock | USD 1.91 0.06 3.24% |
As of the 24th of January, Palisade Bio holds the Coefficient Of Variation of 2385.25, semi deviation of 6.66, and Risk Adjusted Performance of 0.0397. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Palisade Bio, as well as the relationship between them.
Palisade Bio Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Palisade, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to PalisadePalisade Bio's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Palisade Bio Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 13.4 | Strong Buy | 3 | Odds |
Most Palisade analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Palisade stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Palisade Bio, talking to its executives and customers, or listening to Palisade conference calls.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Palisade Bio. If investors know Palisade will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Palisade Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Palisade Bio is measured differently than its book value, which is the value of Palisade that is recorded on the company's balance sheet. Investors also form their own opinion of Palisade Bio's value that differs from its market value or its book value, called intrinsic value, which is Palisade Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Palisade Bio's market value can be influenced by many factors that don't directly affect Palisade Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Palisade Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Palisade Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Palisade Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Palisade Bio 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Palisade Bio's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Palisade Bio.
| 10/26/2025 |
| 01/24/2026 |
If you would invest 0.00 in Palisade Bio on October 26, 2025 and sell it all today you would earn a total of 0.00 from holding Palisade Bio or generate 0.0% return on investment in Palisade Bio over 90 days. Palisade Bio is related to or competes with Aspire BioPharma, Curis, Processa Pharmaceuticals, Briacell Therapeutics, Hoth Therapeutics, Citius Pharmaceuticals, and Dare Bioscience. Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing ... More
Palisade Bio Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Palisade Bio's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Palisade Bio upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 6.99 | |||
| Information Ratio | 0.0315 | |||
| Maximum Drawdown | 31.35 | |||
| Value At Risk | (10.26) | |||
| Potential Upside | 13.86 |
Palisade Bio Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Palisade Bio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Palisade Bio's standard deviation. In reality, there are many statistical measures that can use Palisade Bio historical prices to predict the future Palisade Bio's volatility.| Risk Adjusted Performance | 0.0397 | |||
| Jensen Alpha | 0.3496 | |||
| Total Risk Alpha | (0.39) | |||
| Sortino Ratio | 0.0337 | |||
| Treynor Ratio | (0.45) |
Palisade Bio January 24, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0397 | |||
| Market Risk Adjusted Performance | (0.44) | |||
| Mean Deviation | 6.22 | |||
| Semi Deviation | 6.66 | |||
| Downside Deviation | 6.99 | |||
| Coefficient Of Variation | 2385.25 | |||
| Standard Deviation | 7.48 | |||
| Variance | 56.01 | |||
| Information Ratio | 0.0315 | |||
| Jensen Alpha | 0.3496 | |||
| Total Risk Alpha | (0.39) | |||
| Sortino Ratio | 0.0337 | |||
| Treynor Ratio | (0.45) | |||
| Maximum Drawdown | 31.35 | |||
| Value At Risk | (10.26) | |||
| Potential Upside | 13.86 | |||
| Downside Variance | 48.91 | |||
| Semi Variance | 44.39 | |||
| Expected Short fall | (7.15) | |||
| Skewness | 0.2024 | |||
| Kurtosis | (0.71) |
Palisade Bio Backtested Returns
Palisade Bio appears to be very risky, given 3 months investment horizon. Palisade Bio maintains Sharpe Ratio (i.e., Efficiency) of 0.0674, which implies the firm had a 0.0674 % return per unit of risk over the last 3 months. By analyzing Palisade Bio's technical indicators, you can evaluate if the expected return of 0.51% is justified by implied risk. Please evaluate Palisade Bio's Coefficient Of Variation of 2385.25, risk adjusted performance of 0.0397, and Semi Deviation of 6.66 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Palisade Bio holds a performance score of 5. The company holds a Beta of -0.67, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Palisade Bio are expected to decrease at a much lower rate. During the bear market, Palisade Bio is likely to outperform the market. Please check Palisade Bio's downside variance, and the relationship between the treynor ratio and kurtosis , to make a quick decision on whether Palisade Bio's historical price patterns will revert.
Auto-correlation | 0.07 |
Virtually no predictability
Palisade Bio has virtually no predictability. Overlapping area represents the amount of predictability between Palisade Bio time series from 26th of October 2025 to 10th of December 2025 and 10th of December 2025 to 24th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Palisade Bio price movement. The serial correlation of 0.07 indicates that barely 7.0% of current Palisade Bio price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.07 | |
| Spearman Rank Test | -0.09 | |
| Residual Average | 0.0 | |
| Price Variance | 0.05 |
Palisade Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Palisade Bio Technical Analysis
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Palisade Bio volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Palisade Bio Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Palisade Bio on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Palisade Bio based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Palisade Bio price pattern first instead of the macroeconomic environment surrounding Palisade Bio. By analyzing Palisade Bio's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Palisade Bio's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Palisade Bio specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2025 | 2026 (projected) | Interest Debt Per Share | 0.15 | 0.14 | Revenue Per Share | 0.63 | 0.6 |
Palisade Bio January 24, 2026 Technical Indicators
Most technical analysis of Palisade help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Palisade from various momentum indicators to cycle indicators. When you analyze Palisade charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0397 | |||
| Market Risk Adjusted Performance | (0.44) | |||
| Mean Deviation | 6.22 | |||
| Semi Deviation | 6.66 | |||
| Downside Deviation | 6.99 | |||
| Coefficient Of Variation | 2385.25 | |||
| Standard Deviation | 7.48 | |||
| Variance | 56.01 | |||
| Information Ratio | 0.0315 | |||
| Jensen Alpha | 0.3496 | |||
| Total Risk Alpha | (0.39) | |||
| Sortino Ratio | 0.0337 | |||
| Treynor Ratio | (0.45) | |||
| Maximum Drawdown | 31.35 | |||
| Value At Risk | (10.26) | |||
| Potential Upside | 13.86 | |||
| Downside Variance | 48.91 | |||
| Semi Variance | 44.39 | |||
| Expected Short fall | (7.15) | |||
| Skewness | 0.2024 | |||
| Kurtosis | (0.71) |
Palisade Bio January 24, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Palisade stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 259,470 | ||
| Daily Balance Of Power | 0.46 | ||
| Rate Of Daily Change | 1.03 | ||
| Day Median Price | 1.90 | ||
| Day Typical Price | 1.90 | ||
| Price Action Indicator | 0.04 |
Complementary Tools for Palisade Stock analysis
When running Palisade Bio's price analysis, check to measure Palisade Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Palisade Bio is operating at the current time. Most of Palisade Bio's value examination focuses on studying past and present price action to predict the probability of Palisade Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Palisade Bio's price. Additionally, you may evaluate how the addition of Palisade Bio to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |